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Abstract
Several new immunodeficient mouse models for human cell engraftment have recently been introduced that include the
Rag2
2/2cc
2/2, NOD/SCID, NOD/SCIDcc
2/2 and NOD/SCIDb2m
2/2 strains. Transplantation of these mice with CD34
+
human hematopoietic stem cells leads to prolonged engraftment, multilineage hematopoiesis and the capacity to generate
human immune responses against a variety of antigens. However, the various mouse strains used and different methods of
engrafting human cells are beginning to illustrate strain specific variations in engraftment levels, duration and longevity of
mouse life span. In these proof-of-concept studies we evaluated the Balb/c-Rag1
2/2c
2/2 strain for engraftment by human
fetal liver derived CD34
+ hematopoietic cells using the same protocol found to be effective for Balb/c-Rag2
2/2cc
2/2 mice.
We demonstrate that these mice can be efficiently engrafted and show multilineage human hematopoiesis with human
cells populating different lymphoid organs. Generation of human cells continues beyond a year and production of human
immunoglobulins is noted. Infection with HIV-1 leads to chronic viremia with a resultant CD4 T cell loss. To mimic the
predominant sexual viral transmission, we challenged humanized Rag1
2/2cc
2/2 mice with HIV-1 via vaginal route which
also resulted in chronic viremia and helper T cell loss. Thus these mice can be further exploited for studying human
pathogens that infect the human hematopoietic system in an in vivo setting.
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Introduction
Humanized mice constructed by engrafting human tissues/cells
into immunodeficient mice have greatly advanced research with
viruses such as HIV since human target cells are provided in a
physiological setting thus permitting the study of human disease
pathogenesis, immunity and testing of antivirals in vivo [1,2,3].
While the original SCID-hu thy/liv mouse and SCID-Hu-PBL
models have been very useful to a certain extent in this context
there is no de novo multilineage hematopoiesis with full
complement of all the immune system cells [4,5,6]. The CB17
SCID mice (Prkdc mutation) can spontaneously generate murine
T and B cells as they age (referred to as ‘‘leakiness’’) and have high
levels of NK cell activity, both of which prevent efficient and
prolonged xenoengraftment [7]. Further, the Prkdc mutation
contributes to increased radiosensitivity due to a defect in DNA
repair. Thus, the irradiation step that is sometimes used to
condition the mice for exogenous cell engraftment leads to stunted
growth and decreased life span.
Recent advances in the derivation of newer immunodeficient
mouse strains have permitted improved human cell engraftment
with human cells such as CD34
+ hematopoietic progenitor cells
[1,8]. A variety of mutations are responsible for the SCID (severe
combined immunodeficiency syndrome) phenotype with a
deficiency in different lymphoid cell populations [1]. The
mutations fall into two basic categories: in genes required for
the production of T and/or B cell receptors and genes required
for the response to cytokines involved in the lymphoid cell
maturation/proliferation and interactive communication. The
first category includes Prkdc (protein kinase DNA-activated
catalytic polypeptide), adenosine deaminase (ADA), Janus
kinase-3 (JAK3), Artemis, and the two Rag (recombination-
activating gene) proteins, Rag1 and Rag2. Artemis is an
endonuclease involved in the DNA recombination event required
to generate T and B cell receptors. Rag1 and Rag2 proteins form
a complex with DNA to configure a hairpin structure necessary
for the endonuclease activity of Artemis. Rag1
2/2 and Rag2
2/2
mice phenotypes are similar [9,10]. No leakiness or radiosensi-
tivity is associated with either Rag1 or Rag2 mutations as is
commonly seen in Prkdc
2/2 mice. The second common category
of mutations leading to immunodeficiency is the lack of the
common gamma chain (cc) which is an integral part of receptors
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e20169required for the response to the cytokines IL-2, IL-4, IL-7, IL-9,
IL-15, and IL-21. This leads to a failure in various cell types to
mature and/or expand, including T cells, B cells, and natural
killer (NK) cells [11,12,13]. Other mutations resulting in
decreased NK cell activity (e.g., non-obese diabetic or NOD)
have also been shown to support improved xenoengraftment
[14]. However, a disadvantage with the NOD strain is high
incidence of lymphomas leading to a shortened lifespan.
Exploitation of these above new generation immunodeficient
mice leads to improved humanized mice with higher and more
sustained human cell engraftment. These include mouse strains
such as Rag2
2/2cc
2/2, NOD/SCID, NOD/SCIDcc
2/2, and
NOD/SCIDc2m
2/2 mice [1,8,15,16,17]. Transplantation with
human CD34 hematopoietic stem cells resulted in de novo
multilineage human hematopoiesis with the generation of T cells,
B cells, macrophages and dendritic cells which constitute the
main players in an adaptive immune response. Human cells were
shown to populate the primary and secondary lymphoid system
organs.
The new and improved humanized mice provided new
opportunities in the study of human pathogens that infect the
hematopoietic system. To date, the newer humanized mouse
strains have been evaluated for susceptibility to infection with a
variety of human viruses including EBV, HIV-1, HTLV-1, and
dengue virus to name a few [8,18,19,20,21]. Human T cell
responses have been demonstrated against HIV-1, EBV, toxic
shock syndrome toxin 1, dengue virus and a recombinant
adenoviral vector expressing HCV proteins [8,22,23,24], while
human antibody responses have been shown against HIV-1,
dengue virus, tetanus toxoid, and the haemophilus influenzae B
conjugate vaccine [8,18,20,24,25,26]. Evidence for antigen-
specific antibody class-switching and the detection of neutralizing
antibody following dengue infection attests to the potency of the
adaptive immune response generated in these new and improved
models [18]. Human T and B cell receptors in humanized mice
were found to be highly diverse [23]. Furthermore, mucosal
engraftment is also seen with human cells detected in gut, rectal
and vaginal mucosa [27,28,29,30,31,32,33]. Indeed, efficient
HIV-1 transmission via both vaginal and rectal routes was
demonstrated in RAG-hu and BLT mice which lead to successful
evaluation of new pre-exposure chemo-prophylactics to prevent
HIV-1 sexual transmission [27,29,34].
Despite the above advances, some shortcomings still exist and
newer strains of mice for better hematopoietic cell engraftments
are continually sought. Other important criteria for efficient
production of humanized mice are litter size, robustness after
irradiation and general health issues that may negatively impact
the overall experimentation with this system. With these as a
background, here we characterized a new mouse strain for
engraftment of human CD34
+ hematopoietic stem cells, namely
the Balb/c-Rag1
2/2cc
2/2 mouse. We demonstrate efficient
human cell engraftment and multilineage hematopoiesis using a
similar protocol we previously employed for engraftment of Balb/
c-Rag2
2/2cc
2/2 mice (neonatal gamma irradiation followed by
intrahepatic injection of fetal liver-derived human CD34
+ cells)
[19]. Human hematopoietic cells were found to populate different
lymphoid organs and there was production of human immuno-
globulins IgM, IgG, and IgA. We also show that humanized
Rag1
2/2cc
2/2 mice are susceptible to HIV-1 infection, thus
demonstrating that these mice are useful for the study of human
viral pathogenesis. In addition, we also compared the general
aspects of overall breeding characteristics and survival rates
between Rag1
2/2cc
2/2 and Rag2
2/2cc
2/2 mice.
Materials and Methods
Generation of humanized Rag1
2/2cc
2/2 mice (RAG1-hu
mice)
Balb/c-Rag1
2/2cc
2/2 mice (hitherto referred to as BALB/c-
Rag1
2/2cc
2/2 mice or simply RAG1 mice) were derived and
custom bred (C.129S4IL2RG6C.129S7 Rag1) at the Jackson
Laboratories (Bar Harbor, ME) through a paid contract. Humanized
mice were prepared by engraftment with human fetal liver-derived
CD34
+ hematopoietic progenitor cells as we previously described for
the generation of humanized BALB/c- Rag2
2/2cc
2/2 mice [19].
Mice were maintained at the Colorado State University Painter
Animal Center. These studies have been reviewed and specifically
approved by the CSU Institutional Animal Care and Use Committee
(Protocol 09-1460A). Briefly, newborn mice were conditioned by
irradiating with 350 rads and then injected intrahepatically with 0.5–
1610
6 human CD34
+ cells. Mice were screened for human cell
engraftment at 12 weeks post-reconstitution. Peripheral blood was
collected by tail bleed and red blood cells were lysed by using the
Whole Blood Erythrocyte Lysing Kit (R&D Systems, Minneapolis,
MN). The white blood cell fraction was stained with antibodies
against the human pan-leukocyte marker CD45 (Caltag) and FACS
analyzed to determine the levels of human cell engraftment as we
previously described [19]. For vaginal infections with HIV, female
mice with over 40% engraftment were used.
Flow cytometry
Whole blood was collected and red blood cells lysed as reported
previously [19,27]. White blood cells were stained with CD45-PE,
CD3-PE, CD4-PECy5, CD8-PE, CD14-PE, (Caltag), CD19-PE,
CD123-PE (eBioscience) and CD20-FITC, CD11c-PE-Cy5 (BD
Pharmingen). To evaluate the presence of human hematopoietic cells
in different mouse organs, single cell suspensions were made from
spleen, thymus, lymph nodes, liver and bone marrow. Cells were
stained with different labeled antibodies and subjected to multi-
parametric FACS analysis. Stained cells were analyzed using a
Coulter EPICS XL-MCL FACS analyzer (Beckman Coulter,
Fullerton, CA) or BD LSRII. To determine CD4 T cell loss in
HIV-1 infected mice, they were bled weekly and CD4
+ Tc e l ll e v e l s
were calculated as a ratio of the entire CD3 population
(CD4
+CD3
+:CD4
2CD3
+) as described previously [19]. To establish
baseline CD4
+ T cell ratios, all mice were analyzed prior to infection.
Immunohistochemistry
Immunohistochemistry for human lymphocytes and macro-
phages was performed on 4 mm frozen OCT tissue sections.
Primary antibodies used were anti-human CD45 LCA (clone
2B11+PD7/26, DakoCytomation, Denmark), anti-human CD3
(clone UCHT1, BD Pharmingen), anti-human CD4 (clone RPA-
T4, BD Pharmingen), anti-human CD8 (clone HIT8A, BD
Pharmingen), and anti-human CD68 (clone EBM11, DakoCyto-
mation). Staining was performed as reported previously using the
Vector Laboratories Mouse on Mouse staining kit [19].
Measurement of total human antibody production
Total human antibody production was measured by ELISA
using the Total Human IgG/IgM/IgA Assays (ALerCHEK,
Portland, ME). Serum samples were analyzed following manufac-
turer’s protocol. Secretory IgA was measured as follows: 50 ul
sterile 16PBS was introduced into vaginal vault with a P200 pipet
tip smoothed by briefly passing over a flame. PBS was pipetted
back and forth to collect the vaginal washings. On some occasions,
mucus plugs were visible. To solubilize mucus, samples were
incubated at 37uC for 30 min prior to ELISA testing.
Vagina Transmission of HIV in New Humanized Mice
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2/2cc
2/2 mice. Human CD34 cell reconstituted mice were bled at 12
weeks post-engraftment. RBCs were lysed and the white blood cell fraction was stained for human panleukocyte CD45 marker and FACS analyzed.
The level of human cell engraftment for each mouse is depicted.
doi:10.1371/journal.pone.0020169.g001
Figure 2. FACS analysis of multilineage human hematopoiesis in humanized Rag1
2/2cc
2/2 mice. Single cell suspensions were made
from spleen, bone marrow, lymph node and thymus of humanized Rag1
2/2cc
2/2 mice and were stained with different antibodies to detect human
hematopoietic cell sub-sets. Human anti-CD45 antibody was used to define human leukocytes. From this population human CD3+ T cells (A) as well
as CD4+ and CD8+ T cell subsets were identified in the lymph node, spleen and thymus (B). Dendritic cells were identified by their lack of lineage
staining (CD3, CD19, CD14, CD16, CD20 and CD56) and expression of HLA DR (C). Both myeloid (CD11c) and plasmacytoid (CD123) dendritic cells (D)
were identified in lymphoid organs as were CD14 expressing monocytes (E) and two subsets of CD19 and CD20 expressing B cells (F).
doi:10.1371/journal.pone.0020169.g002
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Mice were infected with HIV-1 by intraperitoneal injection of
100 ul of strain NL4-3 (1.2610‘5 iu) or 100 ul of strain BaL-1
(0.9610‘5 iu). Vaginal infections were performed in a volume of
25 ul with BaL-1 virus (3000 TCID). Sterile P200 tips that had
been previously heated over a flame to smooth any abrasive
surfaces were used to deliver the virus [27]. Anesthetized mice
were held in an inverted position for four minutes post-inoculation
to allow virus to adsorb and to prevent immediate discharge of
virus. Mice were observed daily and blood samples drawn weekly
to assess plasma viremia. To detect HIV-1 in plasma of infected
mice by RT-PCR, RNA was extracted from 25–50 ul of EDTA-
treated plasma using the QIAamp Viral RNA kit (Qiagen,
Valencia, CA). Q-PCR was performed using a primer set specific
for the HIV-1 LTR sequence and a corresponding LTR specific
probe as described previously [19].
Results
Rag1
2/2cc
2/2 mice permit efficient human CD34
+
hematopoietic cell engraftment
Neonatal Rag1
2/2cc
2/2 mice were transplanted with human
fetal liver derived CD34
+ cells after conditioning by irradiation as
we described previously to prepare humanized Rag2
2/2cc
2/2
Figure 3. Immunohistochemical staining of human hematopoietic cells in lymphoid organs. Tissue sections of lymphoid organs (spleen,
lymph node, and thymus) from humanized Rag1
2/2cc
2/2 mice were stained for the presence of human leukocytes. CD45
+ leukocytes (A,B,C), CD68
+
macrophages/dendritic cells (D,E,F), CD3
+ T cells (G,H,I), CD4
+ helper T cells (J,K,L), CD8
+ cytotoxic T cells (M,N,O) and CD20
+ B cells (P,Q,R) were
detected in each of the organs assayed.
doi:10.1371/journal.pone.0020169.g003
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for human cell engraftment in peripheral blood by staining for
human CD45 marker followed by FACS analysis. Summary of
CD45 cell engraftment levels for eighty humanized Rag1
2/2cc
2/2
mice arepresented inFig. 1. Themean peripheralblood human cell
engraftment was 59.3+/22.5% [SEM], with 41% of mice showing
at least 70% engraftment and 5% of mice with less than 20%
engraftment. In comparison, humanized Rag2
2/2cc
2/2 mice
similarlyreconstitutedwithCD34cellshadameanperipheralblood
engraftment of 48.3+/23.0% (data not shown). The higher
peripheral blood engraftment seen in humanized Rag1
2/2cc
2/2
mice over Rag2
2/2cc
2/2 mice is statistically significant (unpaired t
test, P=0.005, n=100 each).
Rag1
2/2cc
2/2 mice support multilineage human
hematopoiesis and human cells populate different
lymphoid organs
After determining the peripheral blood engraftment with
human cells, we next proceeded to evaluate the presence of
different lymphoid and myeloid cell sets in various organs by
multiparametric flow cytometry and immuno-histological staining
(Figs. 2 and 3). Human CD45+ hematopoietic cells were found in
spleen, bone marrow lymph node and thymus of engrafted mice.
Human CD3+CD4+ and CD3+CD8+ T cells were detected in the
spleen, lymph node and thymus. As expected, there was about
twice as many CD4+ T cells as CD8+ T cells in all organs.
Consistent with ongoing de novo lymphopoiesis, CD4/CD8
double positive immature thymocyte population was seen in the
thymus (Fig. 2B). Using a lineage cocktail antibody panel
containing monoclonal antibodies directed against B cells, T cells,
monocytes, NK cells and HLA-DR, dendritic cells were identified
as human CD45 positive, lineage negative and HLA-DR positive
(Fig. 2C). Furthermore, distinct populations of CD123+ cells,
(plasmacytoid dendritic cells i.e., pDCs) and CD11c+ cells
(myeloid dendritic cells i.e., mDCs) were detected in the spleen
and bone marrow, demonstrating the presence of the two main
dendritic cell subsets (Fig. 2D). Monocytes expressing CD14
(Fig. 2E) as well as CD19
+CD20
+ B cells (Fig. 2F) were also
detected in both bone marrow and spleen.
Immunohistochemistry was performed to detect human cell
types in situ in spleen, mesenteric lymph nodes, and thymus
(Fig. 3). Human CD45
+ cells were readily detectable in all the
three organs (Fig. 3A–C), while only rare CD68
+ macrophages
stained positive (Fig. 3D–F). CD3
+ T cells were also found in all
three organs (Fig. 3G–I), as well as the CD4
+ (Fig. 3J–L) and CD8
+
T cell subsets (Fig. 3M–O). CD20
+ B cells were also detected in all
three organs (Fig. 3P–R).
Humanized Rag1
2/2cc
2/2 mice generate human
immunoglobulins
Since all the necessary hematopoietic cell subsets involved in hum-
oral immune response are present in engrafted Rag1
2/2cc
2/2
mice, they are expected to generate human antibodies. Accordingly,
we looked for the presence of human immunoglobulins IgM, IgG,
and IgA in these mouse sera 16 weeks post-CD34 cell engraftment.
Immunoglobulin specific ELISA was used to determine any
quantitative differences when compared with Rag2
2/2cc
2/2
mice (Fig. 4). The mean serum concentration of human IgM was
29.4+/29.0 mg/ml and 92.3+/217.0 mg/ml in humanized
Rag1
2/2cc
2/2 and Rag2
2/2cc
2/2 mice, respectively. The
mean serum concentration of human IgG was 5.6+/21.9 and
3.3+/20.9 mg/ml in Rag1
2/2cc
2/2 and Rag2
2/2cc
2/2 mice,
respectively. The mean serum concentration of human IgA was
0.17+/20.03 and 0.26+/20.11 mg/ml in Rag1
2/2cc
2/2 and
Figure 4. Human antibody production in humanized Rag1
2/2cc
2/2 mice. Blood was drawn at 16 weeks post human CD34 cell engraftment
and sera were analyzed by ELISA to detect different human immunoglobulin classes.
doi:10.1371/journal.pone.0020169.g004
Table 1. Comparison of Rag1
2/2cc
2/2 versus Rag2
2/2cc
2/2 mice for generation of humanized mice (Hu Mice).
Rag2
2/2cc
2/2 Rag1
2/2cc
2/2
Comments:
Rag1
2/2cc
2/2 vs Rag2
2/2cc
2/2
Litter size 3.62 pups 4.35 pups 20.2% more pups
Survival levels at 12 wk engraftment screening 53.7% 79.6% 48.2% higher survival
Average yield
Hu Mice/litter
1.94 3.46 78.4% more Hu Mice
doi:10.1371/journal.pone.0020169.t001
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2/2cc
2/2 mice, respectively. The difference in serum
IgM level was significant (unpaired t test, P=0.003; n=18
Rag1
2/2cc
2/2 and n=20 Rag2
2/2cc
2/2). We also determined
if secretory antibodies exist in the mucosal sites of these mice.
Vaginal washes were subjected to ELISA to detect the levels of
secretory IgA antibody (see Methods). Of the 4 Rag1
2/2cc
2/2
mice assayed, two were positive for IgA in the vaginal mucus (0.19
and 0.15 mg/ml) whereas only one was positive among the 10
Rag2
2/2cc
2/2 mice tested (0.11 mg/ml). It should be noted that
the lone Rag2
2/2cc
2/2 mouse that was positive for sIgA had a
serum IgA concentration that was nearly five-fold higher than any
other mice tested.
Relative yields of humanized Rag1
2/2cc
2/2 mice versus
Rag2
2/2cc
2/2 mice
To evaluate the practical aspects of generation of humanized mice,
we compared the Rag1
2/2cc
2/2 mice to Rag2
2/2cc
2/2 mice. We
found that two factors led to higher yields of humanized Rag1
2/
2cc
2/2 mice (Table 1). First, Rag1
2/2cc
2/2 mouse litters had 20%
more pups per litter than Rag2
2/2cc
2/2 mice (4.35 and 3.62 pups/
litter, respectively) with a statistical significance (unpaired t test,
P=0.022; n=80 Rag1
2/2cc
2/2 litters and n=76 Rag2
2/2cc
2/2
litters). We also observed that Rag1
2/2cc
2/2 pups survived the
engraftment protocol better than Rag2
2/2cc
2/2 pups (survival to
screening at 12 weeks post-engraftment), with 48% higher survival of
humanized Rag1
2/2cc
2/2 mice (79.6% Rag1
2/2cc
2/2 survival
and 53.7% Rag2
2/2cc
2/2survival,respectively).Thedifferencewas
again significant (unpaired t test, P=0.004; n=54 litters each). The
net effect of larger litters together with better survival after the
engraftment protocol resulted in 78.4% higher yields of humanized
Rag1
2/2cc
2/2 mice as compared to Rag2
2/2cc
2/2 mice.
Humanized Rag1
2/2cc
2/2 mice are permissive to HIV-1
infection via intra-peritonial and vaginal mucosal routes
and show CD4 T cell loss
We and others have previously shown that humanized Rag2
2/2
cc
2/2 are susceptible to infection with HIV-1 [19,20,26,35,36].
Here we evaluated if humanized Rag1
2/2cc
2/2 mice also permit
infection with both the R5 and X4 tropic HIV-1. Mice were
injected with either R5 virus (BaL-1; n=5) or X4 virus (NL4-3;
n=6) by the i/p route. Infected animals were assayed for viremia
by Q-RT-PCR for up to 11 weeks post-infection (Fig. 5A). We
found that all virus exposed animals became viremic by the first
week post-infection and, as expected, the control uninfected/
engrafted animals (n=3) were negative for any viral RNA.
Viremia levels on average peaked at 3.8610‘6 RNA copies/ml
plasma at five weeks post-infection infection and the mice were
virus positive throughout the 11 weeks of observation. Since the
helper CD4 T cell depletion is a hallmark of HIV infection, their
levels in peripheral blood were followed by FACS analysis (Fig. 5B).
Our results showed a trend of declining CD4 T cell levels with
both of the viruses during the ten week period of evaluation.
The above data have shown that humanized Rag1
2/2cc
2/2
mice are readily infected by i/p route and have persistent viremia.
However, since the most common route of HIV-1 infection is by the
heterosexual vaginal route, we asked if these mice are susceptible to
infection via this mucosalroute as well. Mice were infected vaginally
with an R5-tropic HIV-1 which is the predominant strain that is
transmitted sexually. Our results showed that all the exposed mice
became infected by the second week with the viral loads reaching a
peak around 5th week and viremia persisting thereafter (Fig. 6A).
Furthermore, the infected mice also exhibited CD4 T cell loss
typical to HIV infection (Fig. 6B). Collectively, these data showed
that humanized Rag1
2/2cc
2/2 mice are permissive for HIV-1
infection by both parenteral and vaginal routes and display the
characteristic helper T cell depletion.
Discussion
Here we have shown that a new strain of immunodeficient mice,
Rag1
2/2cc
2/2 mice, permits efficient engraftment with human
fetal liver derived CD34+ hematopoietic progenitor cells giving
rise to multilineage human hematopoiesis. Infection of these mice
with HIV-1 leads to chronic viremia and subsequent CD4 helper
T cell loss. Furthermore, HIV-1 infection could be established via
vaginal route of infection which is the predominant mode of sexual
viral transmission. Thus, these studies have further expanded the
Figure 5. Humanized Rag1
2/2cc
2/2 mice are susceptible to HIV-1 infection by i/p route and show CD4 T cell decline. Mice were
infected by i/p route with either X4 or R5 HIV-1. Blood was collected weekly and viral RNA extracted from the plasma fraction. Viral RNA loads were
determined by Q-RT-PCR as described in methods. Levels of CD4 T cells were monitored on a weekly basis by FACS to determine their decline.
Baseline values for each of the mice were established prior to infection as described in Methods. A. RNA viral loads. B. CD4 T cell levels.
doi:10.1371/journal.pone.0020169.g005
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engraftment and the study of human pathogens infecting the
human hematopoietic system.
The multilineage human hematopoiesis in these mice is
characterized by the presence of human T cells, B cells,
macrophages and dendritic cells which populated different
primary and secondary lymphoid organs. We have shown the
presence of these cells both by multiparametric FACS analysis and
immunohistochemistry. Peripheral blood evaluated at later times
showed continued presence of human cells beyond one year (data
not shown). Viral challenge data demonstrated that these mice
could be readily infected with both R5 and X4 tropic HIV-1
wherein mice showed viremia within a week post infection by i/p
route. The viremic mice also showed CD4 T cell loss which is a
characteristic feature of HIV-1 infection in the human. Mucosal
transmission by the vaginal route constitutes the predominant
mode of HIV-1 viral transmission. However, details of viral
infection at the portal of entry and systemic spread from there-on
are poorly understood. While studies in macaques using SIV have
shed some light on these early events [37], a suitable small animal
model that employs HIV-1 itself would be more ideal to study
these aspects in further detail. In this context, thus far only two
humanized mouse models with multilineage hematopoiesis have
been shown to be suitable for HIV-1 transmission by the vaginal
and/or rectal routes [27,29,30,34]. These consist of humanized
BLT mice and Rag2
2/2cc
2/2 mice. Here we have shown that
humanized Rag1
2/2cc
2/2 mice are also permissive for vaginal
infection with R5 tropic HIV-1 which is the predominant viral
strain that is transmitted sexually thus providing yet another
mouse model for viral mucosal transmission. This expands the
possibilities for testing novel approaches of anti-HIV microbicides
and other pre-exposure prophylactic measures as was done with
Rag2
2/2cc
2/2 and BLT mice [29,30,34]. Furthermore, since
long-term engraftment is seen, this permits chronic HIV infection
studies such as viral latency and development of drug resistance
during prolonged anti-retroviral therapies [38].
A recent report also demonstrated successful engraftment of
human hematopoietic cells in Rag1
2/2cc
2/2 mice [39]. Cord
blood derived CD34 cells were utilized in this study and only T cells
and B cells were analyzed in the peripheral blood compartment. In
contrast, we used fetal liver derived CD34 cells which are believed
to result in improved and longer lasting engraftment due to their
more primitive lineage characteristics. Moreover, our present
analysis is of a broader scope detecting additional human cell sub-
sets such as macrophages and dendritic cells in different organs in
addition to demonstrating susceptibility to HIV-1 infection.
Due to their unique nature of providing human hematopoietic cells
at various stages of maturation in an in vivo setting, the new
humanized mice are likely to play an ever increasing role in
biomedical research. In the context of HIV, these mice were
effectively used in evaluating novel therapeutic strategies that used
peptides, small molecule drugs, vector-expressed antibodies and zinc-
finger nucleases, siRNAs, aptamers and aptamer-siRNA chimeric
molecules specifically targeted to HIV infected cells in vivo [32,33,
34,40,41,42,43,44,45]. Intensification and scale-up of such promising
studies requires production of these mice in larger numbers for a
thorough evaluation. However, production of humanized mice at
such a large scale is labor intensive and other important factors are
known to come into play. These include efficient breeding among
others. In this context, two factors namely, larger litter size and
increased survival post-engraftment favorably contributed to the
overall higher yield of humanized Rag1
2/2cc
2/2 mice as compared
to Rag2
2/2cc
2/2 mice.
In summary, the new Rag1
2/2cc
2/2 mouse strain permits
efficient human hematopoietic cell engraftment, is readily suscep-
tible to HIV-1 infection by both i/p and vaginal routes, appears to
be generally more robust than Rag2
2/2cc
2/2 mice and therefore
provides yet another choice to generate humanized mice.
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Figure 6. Humanized Rag1
2/2cc
2/2 mice are permissive to HIV-1 infection by vaginal route and show CD4 T cell decline. Mice were
infected by vaginal route with R5 BaL HIV-1. Blood was collected weekly and viral RNA extracted from the plasma fraction. Viral RNA loads were
determined by Q-RT-PCR as described in methods. Levels of CD4 T cells were monitored on a weekly basis by FACS to determine their decline.
Baseline values for each of the mice were established prior to infection as described in Methods. A. RNA viral loads. B. CD4 T cell levels.
doi:10.1371/journal.pone.0020169.g006
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